Misbah Tahir - Dec 16, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Financial Officer
Signature
/s/ Misbah Tahir
Stock symbol
IGMS
Transactions as of
Dec 16, 2022
Transactions value $
-$119,359
Form type
4
Date filed
12/20/2022, 07:09 PM
Previous filing
Nov 28, 2022
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Sale -$27.6K -1.47K -4.43% $18.77 31.7K Dec 16, 2022 Direct F1, F2
transaction IGMS Common Stock Sale -$15.8K -815 -2.57% $19.36 30.9K Dec 16, 2022 Direct F1, F3
transaction IGMS Common Stock Sale -$76K -3.8K -12.3% $20.00 27.1K Dec 19, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This sale was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.